Nitric oxide fails to confer endogenous antiarrhythmic cardioprotection in the primate heart in vitro

British Journal of Pharmacology

Volumn 150, Issue 7, 2007, Pages 893-898

  Pabla, R ^a,b   Curtis, M J ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Antiarrhythmic agents; Endogenous cardioprotection; Ischaemia; Nitric oxide; Reperfusion; Ventricular arrhythmias

Indexed keywords

ARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALLITHRIX JACCUS; CHEMOLUMINESCENCE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ELECTROCARDIOGRAM; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PERFUSION; HEART PROTECTION; HEART RATE; HEART VENTRICLE FIBRILLATION; MALE; MARMOSET; NONHUMAN; PRIMATE; PRIORITY JOURNAL; RABBIT; RAT; REPERFUSION INJURY;

ANIMALS; ARRHYTHMIA; CALLITHRIX; CORONARY CIRCULATION; HEART; HEART RATE; MALE; MYOCARDIAL REPERFUSION INJURY; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

EID: 34047202221     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0707143     Document Type: Article

References (32)

1. Brener SJ, Lincoff AM, Bates ER, Jia G, Armstrong PW, Guetta V et al. (2005). The relationship between baseline risk and mortality in ST-elevation acute myocardial infarction treated with pharmacological reperfusion: insights from the global utilization of strategies to open occluded arteries (GUSTO) V trial. Am Heart J 150: 89-93.
2. Champion HC, Georgakopoulos D, Takimoto E, Isoda T, Wang W, Kass DA (2004). Modulation of in vivo cardiac function by myocyte-specific nitric oxide synthase-3. Circ Res 94: 657-663.
3. Clements-Jewery H., Hearse DJ, Curtis MJ. (2005). Phase 2 ventricular arrhythmias in acute myocardial infarction: a neglected target for therapeutic drug development and safety pharmacology evaluation. Br J Pharmacol 145: 551-564.
4. Cohen MV, Yang X-M, Downey JM (2006). Nitric oxide is a preconditioning mimetic and cardioprotectant and is the basis of many available infarct-sparing strategies. Cardiovasc Res 70: 231-239.
5. Curtis MJ, Hearse DJ (1989a). Reperfusion-induced arrhythmias are critically dependent upon occluded zone size: relevance to the mechanism of arrhythmogenesis. J Mol Cell Cardiol 21: 625-637.
6. Curtis MJ, Pabla R (1997). Nitric oxide supplementation or synthesis block - which is the better approach to treatment of heart disease? Trends Pharmacol Sci 18: 239-244.
7. Ellwood AJ, Curtis MJ (1996). Mechanism of 5-Hydroxytryptamine-induced coronary vasodilatation assessed by direct detection of nitric oxide production in guinea pig isolated heart. Br J Pharmacol 119: 721-729.
8. Ferdinandy P, Schulz R (2003). Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. Br J Pharmacol 138: 532-543.
9. Heimburger RF (1946). Injection into pericardial sac and ligation of coronary artery of rat. Arch Surg 52: 677-689.
10. Jones SP, Bolli R (2006). The ubiquitous role of nitric oxide in cardioprotection. J Mol Cell Cardiol 40: 16-23.
11. Kannengeisser GJ, Lubbe WF, Opie LH (1975). Experimental myocardial infarction with left ventricular failure in the isolated perfused rat heart: Effects of isoproterenol and pacing. J Mol Cell Cardiol 7: 135-151.
12. Kumar K, Nguyen K, Waxman S, Nearing BD, Wellenius GA, Zhao SX et al. (2003). Potent antifibrillatory effects of intrapericardial nitroglycerin in the ischemic porcine heart. J Am Coll Cardiol 41: 1831-1837.
13. Kuzkaya N, Weissmann N, Harrison DG, Dikalov S (2003). Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acide, and thiols: implications for uncoupling endothelial nitric oxide synthase. J Biol Chem 278: 22546-22554.
14. Lavallee M, Vatner SF (1984). Regional myocardial blood flow and necrosis in primates following coronary occlusion. Am J Physiol 246: H635-H639.
15. Looi YH, Kane KA, McPhaden AR, Wainwright CL (2006). Adreno-medullin acts via nitric oxide and peroxynitrite to protect against myocardial ischaemia-induced arrhythmias in anaesthetized rats. Br J Pharmacol 148: 599-609.
16. Mainland D, Harrera L, Sutcliffe MI (1956). Statistical Tables for Use With Binomial Samples: Contingency Tests, Confidence Limits and Sample Size Estimates. New York University College of Medicine Publications: New York.
17. Naseem SA, Koutos MC, Rao PS, Jesse RL, Hess ML, Kukreja RC (1995). Sustained inhibition of nitric oxide by NG-nitro-L-arginine improves myocardial function following ischemia/reperfusion in isolated perfused rat heart. J Mol Cell Cardiol 27: 419-426.
18. Pabla R, Bland-Ward P, Moore PK, Curtis MJ (1995). An endogenous protectant effect of cardiac cGMP against reperfusion-induced ventricular fibrillation in the rat heart. Br J Pharmacology 116: 2923-2930.
19. Pabla R, Curtis MJ (1995). Effects of nitric oxide modulation on cardiac arrhythmias in the rat isolated heart. Circulation Res 77: 984-992.
20. Pabla R, Curtis MJ (1996a). Endogenous protection against reperfusion-induced ventricular fibrillation: role of neuronal versus non-neuronal sources of nitric oxide and species-dependence in the rat versus rabbit isolated heart. J Molec Cell Cardiol 28: 2097-2010.
21. Pabla R, Curtis MJ (1996b). Effect of endogenous nitric oxide on cardiac systolic and diastolic function during ischemia and reperfusion in the rat isolated heart. J Mol Cell Cardiol 28: 2011-2021.
22. Parratt JR. (1993). Endogenous myocardial protective (antiarrhythmic) substances. Cardiovasc Res 27: 693-702.
23. Ravingerova T, Tribulova N, Slezak J, Curtis MJ (1995). Brief, intermediate and prolonged ischemia in the isolated crystalloid perfused rat heart: relationship between susceptibility to arrhythmias and degree of ultrastructural injury. J Mol Cell Cardiol 27: 1937-1951.
24. KI blockade: A new antiarrhythmic mechanism?. Effect of RP 58866 on ventricular arrhythmias in rat, rabbit and primate. Circulation 87: 1979-1989.
25. Shen Y-T, Fallon JT, Iwase M, Vatner SF (1996). Innate protection of baboon myocardium: effects of coronary artery occlusion and reperfusion. Am J Physiol 270: H1812-H1818.
26. Sun W., Wainwright CL (1997). The role of nitric oxide in modulating ischaemia-induced arrhythmias in rats. J Cardiovasc Pharmacol 29: 554-562.
27. Swissa M, Ohara T, Lee M-H, Kaul S, Shah PK, Hayashi H et al. (2002). Sildenafil-nitric oxide donor combination promotes ventricular tachyarrhythmias in the swine right ventricle. Am J Physiol 282: H1787-H1792.
28. Takimoto E, Champion HC, Li M, Ren S, Rodriguez ER, Tavazzi B et al. (2005). Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure overload. J Clin Invest 115: 1221-1231.
29. Tsuchihashi K, Curtis MJ (1991). Influence of tedisamil on the initiation and maintenance of ventricular fibrillation: chemical defibrillation by Ito blockade? J Cardiovasc Pharmacol 18: 445-456.
30. Walker MJA, Curtis MJ, Hearse DJ, Campbell RWF, Janse MJ, Yellon DM et al. (1988). The Lambeth Conventions: guidelines for the study of arrhythmias in ischemia, infarction and reperfusion. Cardiovasc Res 22: 447-455.
31. Xia Y, Dawson VL, Dawson TM, Snyder SH, Zweier JL (1996). Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc Natl Acad Sci USA 93: 6670-6674.
32. Zweier JL, Talukder MAH (2006). The role of oxidants and free radicals in reperfusion injury. Cardiovasc Res 70: 181-190.